Founded in 2012, Biori Biotechnology operates within the biotechnology sector with a focus on upstream raw materials for molecular diagnostics, particularly enzyme-based reagents and premixed solution products. The company also develops GMP-grade enzyme raw materials for mRNA vaccine production and quality control reagents for biological products, which are widely recognized for their performance and reliability.